Matrix Metalloproteinases 2 and 9 Are Differentially Expressed in Patients with Indeterminate and Cardiac Clinical Forms of Chagas Disease

Dilated chronic cardiomyopathy (DCC) from Chagas disease is associated with myocardial remodeling and interstitial fibrosis, resulting in extracellular matrix (ECM) changes. In this study, we characterized for the first time the serum matrix metalloproteinase 2 (MMP-2) and MMP-9 levels, as well as their main cell sources in peripheral blood mononuclear cells from patients presenting with the indeterminate (IND) or cardiac (CARD) clinical form of Chagas disease. Our results showed that serum levels of MMP-9 are associated with the severity of Chagas disease. The analysis of MMP production by T lymphocytes showed that CD8(+) T cells are the main mononuclear leukocyte source of both MMP-2 and MMP-9 molecules. Using a new 3-dimensional model of fibrosis, we observed that sera from patients with Chagas disease induced an increase in the extracellular matrix components in cardiac spheroids. Furthermore, MMP-2 and MMP-9 showed different correlations with matrix proteins and inflammatory cytokines in patients with Chagas disease. Our results suggest that MMP-2 and MMP-9 show distinct activities in Chagas disease pathogenesis. While MMP-9 seems to be involved in the inflammation and cardiac remodeling of Chagas disease, MMP-2 does not correlate with inflammatory molecules.

Citing Articles

Exploring the Dimensions of Pre-Clinical Research: 3D Cultures as an Investigative Model of Cardiac Fibrosis in Chagas Disease.

Seydel C, Gonzaga B, Coelho L, Garzoni L Biomedicines. 2024; 12(7).

PMID: 39061986 PMC: 11274318. DOI: 10.3390/biomedicines12071410.

Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease.

Mendes V, Rimolo L, de Lima A, Ferreira R, Oliveira L, Nisimura L J Am Heart Assoc. 2023; 12(12):e028810.

PMID: 37313975 PMC: 10356036. DOI: 10.1161/JAHA.122.028810.

Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels.

Bestetti R, Dellalibera-Joviliano R, Rizzi E, Bonacio G, Faria-Jr M, Furlan-Daniel R Cardiol Res Pract. 2023; 2023:8484697.

PMID: 37122872 PMC: 10132902. DOI: 10.1155/2023/8484697.

Risk Factors for Progression to Chronic Chagas Cardiomyopathy: A Systematic Review and Meta-Analysis.

Cutshaw M, Sciaudone M, Bowman N Am J Trop Med Hyg. 2023; 108(4):791-800.

PMID: 36848894 PMC: 10076993. DOI: 10.4269/ajtmh.22-0630.

Call for Consensus in the Evaluation of Circulating Matrix Metalloproteinases in Chagas Disease.

Bautista-Lopez N, Schulz R Am J Trop Med Hyg. 2022; .

PMID: 35895410 PMC: 9490674. DOI: 10.4269/ajtmh.21-0860.

References

Menezes C, Costa G, Gollob K, Dutra W . Clinical aspects of Chagas disease and implications for novel therapies. Drug Dev Res. 2012; 72(6):471-479. PMC: 3259567. DOI: 10.1002/ddr.20454. View

Vandooren J, Geurts N, Martens E, Van den Steen P, Opdenakker G . Zymography methods for visualizing hydrolytic enzymes. Nat Methods. 2013; 10(3):211-20. DOI: 10.1038/nmeth.2371. View

Clark R, Nance J, Noor S, Wilson E . T-cell production of matrix metalloproteinases and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain. ASN Neuro. 2011; 3(1):e00049. PMC: 3024837. DOI: 10.1042/AN20100027. View

Meirelles M, Miranda C, De Souza W, Barbosa H . Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro. Eur J Cell Biol. 1986; 41(2):198-206. View

Spinale F, Janicki J, Zile M . Membrane-associated matrix proteolysis and heart failure. Circ Res. 2013; 112(1):195-208. PMC: 4026203. DOI: 10.1161/CIRCRESAHA.112.266882. View

Mannello F, Medda V . Nuclear localization of matrix metalloproteinases. Prog Histochem Cytochem. 2012; 47(1):27-58. DOI: 10.1016/j.proghi.2011.12.002. View

Li Y, McTiernan C, Feldman A . Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res. 2000; 46(2):214-24. DOI: 10.1016/s0008-6363(00)00003-1. View

Parks W, Wilson C, Lopez-Boado Y . Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004; 4(8):617-29. DOI: 10.1038/nri1418. View

Manque P, Probst C, Probst C, Pereira M, Rampazzo R, Ozaki L . Trypanosoma cruzi infection induces a global host cell response in cardiomyocytes. Infect Immun. 2011; 79(5):1855-62. PMC: 3088143. DOI: 10.1128/IAI.00643-10. View

10.

Geurts N, Opdenakker G, Van den Steen P . Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections. Pharmacol Ther. 2011; 133(3):257-79. DOI: 10.1016/j.pharmthera.2011.11.008. View

11.

Edsparr K, Basse P, Goldfarb R, Albertsson P . Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation. Cancer Microenviron. 2011; 4(3):351-60. PMC: 3234320. DOI: 10.1007/s12307-010-0057-0. View

12.

Moncayo A, Silveira A . Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz. 2009; 104 Suppl 1:17-30. DOI: 10.1590/s0074-02762009000900005. View

13.

Rocha M, Teixeira M, Ribeiro A . An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther. 2007; 5(4):727-43. DOI: 10.1586/14787210.5.4.727. View

14.

Schulz R . Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol. 2006; 47:211-42. DOI: 10.1146/annurev.pharmtox.47.120505.105230. View

15.

Deschamps A, Spinale F . Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc Res. 2006; 69(3):666-76. DOI: 10.1016/j.cardiores.2005.10.004. View

16.

Gomes J, Campi-Azevedo A, Teixeira-Carvalho A, Silveira-Lemos D, Vitelli-Avelar D, Sathler-Avelar R . Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease. Immunobiology. 2012; 217(10):1005-16. DOI: 10.1016/j.imbio.2012.01.014. View

17.

Matsunaga T, Abe N, Kameda K, Hagii J, Fujita N, Onodera H . Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction. Int J Cardiol. 2005; 105(2):203-8. DOI: 10.1016/j.ijcard.2005.01.011. View

18.

Brunner S, Kim J, Methe H . Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease. Am J Cardiol. 2010; 105(4):429-34. DOI: 10.1016/j.amjcard.2009.10.013. View

19.

de Oliveira F, Araujo-Jorge T, de Souza E, de Oliveira G, Degrave W, Feige J . Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease. PLoS Negl Trop Dis. 2012; 6(6):e1696. PMC: 3373641. DOI: 10.1371/journal.pntd.0001696. View

20.

Nagase H, Visse R, Murphy G . Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69(3):562-73. DOI: 10.1016/j.cardiores.2005.12.002. View